83
Participants
Start Date
October 22, 2021
Primary Completion Date
October 9, 2025
Study Completion Date
August 20, 2029
Crovalimab
Crovalimab will be administered at a dose of 1000 milligrams (mg) intravenous (IV) (for participants with body weight at least 40 (\>=) and up to 100 kilograms (kg) or 1500 mg IV (for participants with body weight \>=100kg) on Week 1 Day 1. On Week 1 Day 2 and on Weeks 2, 3 and 4, it will be administered at a dose of 340 mg subcutaneously (SC). On Week 5 and every 4 weeks (Q4W) thereafter, it will be administered at a dose of 680 mg SC (for participants with body weight \>= 40kg to \<100kg) or 1020 mg SC (for participants with body weight \>=100kg).
Del- Pesti Centrumkorhaz- Szent Laszlo Korhaz Telephely, Budapest
UZ Leuven Gasthuisberg, Leuven
Instituto Nacional de Ciencias, Mexico City
A.O. Universitaria S. Martino Di Genova, Genoa
Emory Children's Center, Atlanta
Medizinische Hochschule Hannover, Hanover
Hopital Lapeyronie, Montpellier
Hôpital Arnaud de Villeneuve, Montpellier
Istanbul University Istanbul Medical Faculty, Istanbul
Hospital Universitario Virgen del Rocío, Seville
Kocaeli University Medical Faculty, Kocaeli
Necmettin Erbakan University Meram Medical Faculty, Konya
The Ohio State University Wexner Medical Center, Columbus
Malatya Park Hospital, Malatya
Hospital de Especialidades Puerta de Hierro S.A de C.V., Zapopan
Universitätsklinikum Essen, Essen
Klinik für Nephrologie des Universitätsklinikum Essen, Essen
Cincinnati Children's Hospital Medical Center, Cincinnati
Rabin Medical Center, Petah Tikva
Klinik II für Nephrologie, Rheumatologie, Diabetologie und Allgemeine Innere Medizin, Cologne
Sheba MC, Ramat Gan
Washington University, St Louis
"Hospital Universitario Dr. Jose Eleuterio Gonzalez", Monterrey
Hôpital Robert Debré, Paris
Gh Necker Enfants Malades, Paris
Hopital Tenon, Paris
UT Health Science Center, San Antonio
Children's Hospital Colorado, Aurora
University of California Irvine Chao Family Comprehensive Cancer Center, Orange
Univ of CA San Francisco, San Francisco
Peking University First Hospital, Beijing
All India Institute Of Medical Sciences (AIIMS), New Delhi
Medanta-The Medicity, Gurgaon
Rambam Medical Center, Haifa
Santa Casa de Misericordia, Belo Horizonte
UPECLIN Hospital das Clinicas da Faculdade de Medicina de Botucatu, Botucatu
Hospital das Clinicas - FMUSP, São Paulo
Vancouver General Hospital, Vancouver
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome
Nagoya University Hospital, Aichi
Saitama Medical University Hospital, Saitama
The University of Tokyo Hospital, Tokyo
Hospital General de México, Distrito Federal
Instytut ?Centrum Zdrowia Matki Polki, Lodz
Hospital Clinic i Provincial, Barcelona
Collaborators (1)
Chugai Pharmaceutical
INDUSTRY
Hoffmann-La Roche
INDUSTRY